These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 795597)
1. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep]. Baldrighi V; Barbaresi F; Plancher AC; Portioli I Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597 [No Abstract] [Full Text] [Related]
2. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep]. Parenti B; Selvaggi R Clin Ter; 1980 Jan; 92(2):155-63. PubMed ID: 7389275 [No Abstract] [Full Text] [Related]
3. [Results of the clinical testing of a new coronary drug, Cormelian]. Pollter J Fortschr Med; 1972 Apr; 90(10):399-404. PubMed ID: 4616888 [No Abstract] [Full Text] [Related]
4. [Noninvasive quantitative evaluation of cardiac reverse--effects of dilazep (adenosine like agent)]. Morishita T; Arai C; Abe N; Takeuchi K; Hasegawa M; Takayama Y; Emori I; Yoshinori K Kokyu To Junkan; 1988 Jun; 36(6):675-9. PubMed ID: 3217607 [No Abstract] [Full Text] [Related]
5. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study]. Gillner H; Pollter J; Schnitker J; Sievers HG; Zylmann G Med Monatsschr; 1975 Feb; 29(2):82-7. PubMed ID: 1092990 [No Abstract] [Full Text] [Related]
6. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina]. Romano M; De Caprio L; Scarafile P; Carlomagno A; Meccariello P; Condorelli M Minerva Cardioangiol; 1980; 28(7-8):489-94. PubMed ID: 7005711 [No Abstract] [Full Text] [Related]
7. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians]. Pollter J; Schnitker J Med Welt; 1975 Oct; 26(44):2007-12. PubMed ID: 1186488 [No Abstract] [Full Text] [Related]
8. [Cormelian (Dilazep) a new coronary active substance]. Reuter H Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598 [No Abstract] [Full Text] [Related]
9. [Dilazep]. Pirani R; Gruppillo P G Ital Cardiol; 1980; 10(10):1419-25. PubMed ID: 7016654 [No Abstract] [Full Text] [Related]
10. [Cardiodynamic changes induced with dilazep in chronic coronary insufficiency]. Fogari R G Ital Cardiol; 1980; 10(12):1675-8. PubMed ID: 7250592 [TBL] [Abstract][Full Text] [Related]
11. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation]. Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607 [No Abstract] [Full Text] [Related]
12. Cardiovascular effects of a single high dose of dilazep by oral route. Ibba GV; Terrosu P; Franceschino V; Contini GM Int J Cardiol; 1986 Jun; 11(3):337-48. PubMed ID: 3721632 [TBL] [Abstract][Full Text] [Related]
13. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950 [No Abstract] [Full Text] [Related]
14. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951 [No Abstract] [Full Text] [Related]
15. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714 [No Abstract] [Full Text] [Related]
16. Effect of dilazep on hemoglobin-oxygen affinity in patients with ischemic heart disease. Koshu M; Sugimoto T; Terada Y; Uraoka T Jpn Heart J; 1985 Jul; 26(4):521-30. PubMed ID: 3903248 [TBL] [Abstract][Full Text] [Related]
17. [Clinical effects of dilazep dihydrochloride on glomerulonephritis]. Morozumi K; Sohmiya S; Kobayashi M; Sato M; Fujinami T; Yoshida A; Gotoh I Nihon Jinzo Gakkai Shi; 1983 Oct; 25(10):1189-99. PubMed ID: 6674642 [No Abstract] [Full Text] [Related]
18. Efficacy of Dilazep in patients with previous myocardial infarction participating in a cardiac rehabilitation programme. Grasso S; Cefis M; Fonte S; Ugolini C; Cerri B Int J Clin Pharmacol Res; 1983; 3(4):271-4. PubMed ID: 6678824 [TBL] [Abstract][Full Text] [Related]
19. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270 [No Abstract] [Full Text] [Related]